开发一个凝血障碍病单元的发展
Timea Szanto1,2, Tuukka Helin3, Lotta Joutsi-Korhonen3
1Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Centre, Comprehensive Care Centre of Hemophilia and Allied Disorders (EAHAD), Helsinki University Hospital, Helsinki, Finland.
Seminars in thrombosis and hemostasis
|February 19, 2024
概括
赫尔辛基凝血障碍病组提供24/7的出血和血栓的诊断和管理. 它强调了强大的临床-实验室联系,知识共享和国际合作,以推进血栓形成和血液静止治疗.
科学领域:
- 血液学 血液学 血液学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 赫尔辛基的凝血障碍病组为出血和血栓形成提供持续的诊断和管理服务.
- 临床实践和实验室功能之间的强有力的整合已经成为二十多年来优先事项.
研究的目的:
- 描述赫尔辛基凝血障碍病组的发展和运行模式.
- 突出该部门在血栓形成和血液静止方面的地方,国家和国际合作中的作用.
主要方法:
- 通过电话和电子书面报告提供24 / 7咨询服务.
- 门诊诊所用于血栓形成和血静转诊.
- 积极参与当地,北欧,欧洲和国际科学论坛,制定指南.
主要成果:
- 建立了一个全面的服务,用于凝血障碍的诊断和管理.
- 培养了强大的跨学科合作和知识交流.
- 参与教育活动并适应新出现的挑战,如COVID-19相关的凝血病和疫苗诱导的血栓形成.
结论:
- 赫尔辛基凝血障碍病组作为综合护理和血栓形成和血液静止的持续学习的典范.
- 国际合作和遵守全球基准对于保持高标准的护理至关重要.
- 该部门旨在扩大国际参与,并为该学科的全球进步做出贡献.
相关概念视频
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K
Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K


